Drug Type Small molecule drug |
Synonyms + [1] |
Target |
Mechanism D2 receptor antagonists(Dopamine D2 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization- |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC15H20Cl2N2O3 |
InChIKeyWAOQONBSWFLFPE-VIFPVBQESA-N |
CAS Registry84225-95-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Raclopride | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Psychotic Disorders | Phase 3 | EU | - | - |
Phase 4 | 88 | qngrcxwecx(tmglqgsjxz) = mtrwntxjty fruhbtdzpq (tboazkwtdl, brrgkabpet - bcmdzrcbfs) View more | - | 27 Apr 2020 | |||
Not Applicable | - | imnheqqopp(tufwtqjboa) = zhpnlkwscb rhcjebhglo (cworcjgotl ) View more | Positive | 19 Jun 2016 | |||
imnheqqopp(tufwtqjboa) = mkfyurjucu rhcjebhglo (cworcjgotl ) View more |